CIM
AMGN icon

Cambria Investment Management’s Amgen AMGN Stock Holding History

Cambria Investment Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$757K Buy
2,152
+262
+14% +$93.4K 0.04% 275
2025
Q4 		$619K Buy
1,890
+605
+47% +$192K 0.04% 360
2025
Q3 		$363K Buy
+1,285
New +$373K 0.02% 403
2019
Q4 		– Sell
-24,265
Closed -$4.7M – 182
2019
Q3 		$4.7M Sell
24,265
-232
-0.9% -$44.5K 0.7% 61
2019
Q2 		$4.51M Buy
24,497
+1,924
+9% +$345K 0.69% 68
2019
Q1 		$4.29M Buy
22,573
+1,460
+7% +$279K 0.66% 72
2018
Q4 		$4.11M Sell
21,113
-1,324
-6% -$258K 0.7% 47
2018
Q3 		$4.65M Sell
22,437
-727
-3% -$143K 0.68% 43
2018
Q2 		$4.43M Sell
23,164
-2,122
-8% -$375K 0.66% 52
2018
Q1 		$4.31M Sell
25,286
-8,414
-25% -$1.54M 0.63% 74
2017
Q4 		$5.86M Buy
33,700
+5,004
+17% +$886K 0.82% 63
2017
Q3 		$5.35M Buy
28,696
+2
+0% +$354 0.82% 54
2017
Q2 		$4.94M Buy
+28,694
New +$4.67M 1.06% 28
2015
Q4 		– Sell
-65
Closed -$9K – 161
2015
Q3 		$9K Buy
+65
New +$10.2K ﹤0.01% 280

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Cambria Investment Management's AMGN Position: Q1 2026 in Review

Cambria Investment Management increased its Amgen (AMGN) stake by 14% in Q1 2026, buying an estimated $93.4K and bringing the position to 2,152 shares worth $757K. The position accounts for 0.04% of the portfolio, ranked #275.

Cambria Investment Management first reported a position in AMGN in Q3 2015 and has held it in 14 quarters since. The position peaked at $5.86M in Q4 2017. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Cambria Investment Management held 2,152 shares of Amgen worth $757K as of Q1 2026.
  • Cambria Investment Management bought 262 Amgen shares in Q1 2026, an estimated $93.4K.
  • Amgen made up 0.04% of Cambria Investment Management's portfolio in Q1 2026, its #275 holding.
  • Cambria Investment Management first reported a position in Amgen in Q3 2015 and has held it in 14 quarters since.
  • Cambria Investment Management's Amgen position peaked at $5.86M in Q4 2017.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Cambria Investment Management's 13F filing for Q1 2026, filed 15 May 2026.